AbbVie Raises 2026 Profit Outlook and Lifts Dividend 5.2%
After its third-quarter report, AbbVie raised its 2026 adjusted EPS guidance to $13.95-$13.99 and increased its quarterly dividend 5.2% to $1.82 per share.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
AbbVie reported third-quarter 2026 results and raised its full-year adjusted earnings per share outlook. The company now expects $13.95 to $13.99 per share, up from the earlier range of $13.76 to $13.96.
The board also declared a quarterly cash dividend of $1.82 per share, 5.2% higher than before. The payment is scheduled for February 16, 2027, to shareholders of record as of January 15, 2027.
The guidance includes an unfavorable impact of $0.69 per share from acquired IPR&D and milestone expenses booked year to date through the third quarter. These details were reported by RTTNews via dpa-AFX and distributed by TradingView.
why it matters
For the market, the update signals improving profitability at the drugmaker and a continued commitment to shareholder payouts. According to the report, ABBV was trading at about $292 in pre-market trade. Attention now turns to the quarterly details and management commentary on the earnings call, including any outlook for 2027.
market impact
ABBV shares: higher guidance and dividend support investor interest
- AbbVie shares (ABBV) pressure up — higher profit guidance and dividend improve the company's outlook
tags
instruments
sources
- AbbVie (ABBV) Lifts FY26 EPS Guidance; Raises Dividend 5.2% — TradingView, 30 October 2026 at 11:46 UTC
- ROUNDUP: AbbVie Raises FY26 Adj. EPS Outlook; Boost Dividend 5.2% — TradingView, 30 October 2026 at 12:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗